Blog

Posts

17 May 19

Host Cell Proteins Analysis

The development and validation of a process specific assay for host cell proteins (HCP) determination in therapeutic recombinant proteins should follow the specifications contained in monograph 2.6.34 of the European Pharmacopeia in a step by step approach:

1. Production of the HCP antigens

Capillary electrophoresis PA800
04 Mar 19

Electrophoresis in Quality Control of Biologics

Electrophoresis is an analytical technique widely used for purity determination and identification of therapeutic proteins. This technique is based in the migration of the proteins under an electrical field according their electrophoretic mobility. Depending of the type of the electrophoresis, different quality attributes of the protein can be measured. Sensitivity, robustness and throughput will depend of the format used, being the classical flat/vertical gel formats displaced by the newest capillary formats due to their inherent advantages.

29 Jan 19

Interview to Kymos CEO in Healthcare & Life Sciences Review

Joan Puig de Dou, CEO of Kymos Pharma, a Spanish analytical CRO, shares his insights in the changing dynamics of the industry and explains how remaining independent in the face of industry consolidation is a strategic priority to leverage both quality and specialization for the company’s clients.

The interview has been published online in Pharma Boardroom:

https://pharmaboardroom.com/interviews/joan-puig-de-dou-ceo-kymos-pharma-spain/

Pharmaceutical vials for injection
08 Jan 19

In-Use Microbial Stability

In-use stability testing for multidose products was initially based in the Note for Guidance on In-use Stability Testing of Human Medicinal Products of the CPMP of the EMA, in March 2001. According to it the purpose of in-use stability testing is to establish a period of time during which a multidose product can be used whilst retaining quality within an accepted specification once the container is opened.